← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 1, 2007Last known activity
Dec 1, 2025
Timeline
1990s
- Jun 1, 1995
SOLTI Breast Cancer Research Group— Founded
Drugs by trial phase (36 distinct, 38 trials)
Phase 3 (11 own, 0 via acquisition)
Phase 2 (21 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Recent trials (41)
- NCT07237256CollaboratorPhase 3Dec 1, 2025
- NCT06764186CollaboratorPhase 3Jan 7, 2025
- NCT06236269Lead sponsorPhase 2Mar 15, 2024
- NCT06078384CollaboratorPhase 2Feb 1, 2024
- NCT05982093Lead sponsorPhase 2Aug 31, 2023
- NCT05569811Lead sponsorPhase 2Nov 25, 2022
- NCT05451784Study chairPhase 1/Phase 2Jul 25, 2022
- NCT05451784CollaboratorPhase 1/Phase 2Jul 25, 2022
- NCT05296746Lead sponsorPhase 2May 3, 2022
- NCT05207709Lead sponsorPhase 3Mar 28, 2022
- NCT05340413Study chairPhase 2Mar 25, 2022
- NCT05340413Lead sponsorPhase 2Mar 25, 2022
- NCT04797728Lead sponsorEarly Phase 1May 9, 2021
- NCT04802876Lead sponsorPhase 2Apr 12, 2021
- NCT04759248Lead sponsorPhase 2Mar 15, 2021
Details
- Founded
- Barcelona, ES Jun 1, 1995
- Last known activity
- Dec 1, 2025